,5,6 Tocilizumab (TCZ), a monoclonal antibody against IL-6RA that inhibits IL-6 activity,7 was recently tested in SSc patients in two large phase 2/3 trials.8 The gene discussed is IL6R; the disease is systemic sclerosis.